Cabaletta Bio, Inc. — Director's Dealing 2019

Oct 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2019-10-24

Reporting Person: Chang David J. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-24	Stock Option (Right to Buy)	$11.00	A	48836	Acquired	2029-10-23	Common Stock (48836)	Direct

Footnotes

F1: This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter.